Abstract

Using the URL or DOI link below will
ensure access to this page indefinitely

Based on your IP address, your paper is being delivered by:

New York, USA

Processing request.

Illinois, USA

Processing request.

Brussels, Belgium

Processing request.

Seoul, Korea

Processing request.

California, USA

Processing request.

If you have any problems downloading this paper,please click on another Download Location above, or view our FAQFile name: SSRN-id1632571. ; Size: 2281K

You will receive a perfect bound, 8.5 x 11 inch, black and white printed copy of this PDF document with a glossy color cover. Currently shipping to U.S. addresses only. Your order will ship within 3 business days. For more details, view our FAQ.

Quantity:Total Price = $9.99 plus shipping (U.S. Only)

If you have any problems with this purchase, please contact us for assistance by email: Support@SSRN.com or by phone: 877-SSRNHelp (877 777 6435) in the United States, or +1 585 442 8170 outside of the United States. We are open Monday through Friday between the hours of 8:30AM and 6:00PM, United States Eastern.

The Myth of Patent Neutrality: Property, Patents, Animal Rights and Animal Welfare in Commissioner of Patents V. President and Fellows of Harvard College

In Commissioner of Patents v. President and Fellows of Harvard College, the Supreme Court of Canada held that higher life forms such as an oncomouse are not patentable in Canada. Although disagreeing on the issue of patentability, the majority and dissenting judgments were consistent to the extent that both rejected ethical arguments concerning the legitimacy of granting patents in higher life forms; both took the view that, given the ostensible ethical neutrality of the patent regime, such arguments are misplaced. Ethical concerns arise not as part of the patenting process, but during upstream research and development and downstream commercial exploitation. The objective of this analysis is to take exception to the reasoning in both the majority and dissenting judgments concerning patent neutrality. Using the examples of animal rights and animal welfare, two controversial ethical issues raised in the decision, this analysis will demonstrate that the patent system is not ethical neutral in relation to the interests of non-human animals who are made to be the objects of intellectual property rights.